Literature DB >> 8162332

Review of the etiopathomechanism of vitiligo: a convergence theory.

I C Le Poole1, P K Das, R M van den Wijngaard, J D Bos, W Westerhof.   

Abstract

Vitiligo is an acquired melanin pigmentary disorder manifesting itself by expanding depigmented lesions of the skin. To date, the etiopathomechanism of vitiligo has not been convincingly elucidated and a number of seemingly mutually opposed hypotheses with equal likelihood still coexist. Concurrent theories on vitiligo etiology, together with supportive evidence, are reviewed here. Due to the observed variation in clinical manifestations of the disease, it seems likely that the etiology of vitiligo may differ among patients. Therefore several theories on vitiligo etiopathogenesis have been combined to formulate a convergence theory for vitiligo, also presented in this article. This theory states that stress, accumulation of toxic compounds, infection, autoimmunity, mutations, altered cellular environment and impaired melanocyte migration and/or proliferation can all contribute to vitiligo etiopathogenesis in varying proportions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8162332     DOI: 10.1111/j.1600-0625.1993.tb00023.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  36 in total

1.  Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.

Authors:  I C Le Poole; R M van den Wijngaard; W Westerhof; P K Das
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

Review 2.  Involvement of adenylate cyclase/cAMP/CREB and SOX9/MITF in melanogenesis to prevent vitiligo.

Authors:  Navneet Arora; Ehraz Mehmood Siddiqui; Sidharth Mehan
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

Review 3.  Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.

Authors:  Katia Boniface; Julien Seneschal; Mauro Picardo; Alain Taïeb
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

4.  Update on the genetics characterization of vitiligo.

Authors:  Hani A Al-Shobaili
Journal:  Int J Health Sci (Qassim)       Date:  2011-07

Review 5.  Multifaceted pathways protect human skin from UV radiation.

Authors:  Vivek T Natarajan; Parul Ganju; Amrita Ramkumar; Ritika Grover; Rajesh S Gokhale
Journal:  Nat Chem Biol       Date:  2014-07       Impact factor: 15.040

6.  Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation.

Authors:  Jonathan M Eby; Hee-Kap Kang; Jared Klarquist; Shilpak Chatterjee; Jeffrey A Mosenson; Michael I Nishimura; Elizabeth Garrett-Mayer; B Jack Longley; Victor H Engelhard; Shikhar Mehrotra; I Caroline Le Poole
Journal:  Pigment Cell Melanoma Res       Date:  2014-07-21       Impact factor: 4.693

7.  Oxidative stress level and tyrosinase activity in vitiligo patients.

Authors:  M Eskandani; J Golchai; N Pirooznia; S Hasannia
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

8.  Short-term effects of 308-nm xenon-chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study.

Authors:  Seok-Beom Hong; Hyun-Ho Park; Mu-Hyoung Lee
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

9.  Impact of HLA-G in the outcome of vitiligo in Tunisian patients.

Authors:  Akrem Jalel; Aouadi Ridha; Duboisier Laurent; Moureaux Philippe; M H Hamdaoui
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

10.  Comparison of plasma malondialdehyde, glutathione, glutathione peroxidase, hydroxyproline and selenium levels in patients with vitiligo and healthy controls.

Authors:  I Cetin Ozturk; Kadir Batcioglu; Fikret Karatas; Ersoy Hazneci; Metin Genc
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.